PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.27%
Revenue growth above 1.5x 3141.T's 2.63%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
11.47%
Gross profit growth above 1.5x 3141.T's 3.78%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
16.10%
EBIT growth similar to 3141.T's 15.39%. Walter Schloss might infer both firms share similar operational efficiencies.
15.53%
Operating income growth under 50% of 3141.T's 43.60%. Michael Burry would be concerned about deeper cost or sales issues.
12.54%
Positive net income growth while 3141.T is negative. John Neff might see a big relative performance advantage.
12.53%
Positive EPS growth while 3141.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
12.53%
Positive diluted EPS growth while 3141.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
81.38%
10Y revenue/share CAGR above 1.5x 3141.T's 32.67%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
81.38%
5Y revenue/share CAGR above 1.5x 3141.T's 32.67%. David Dodd would look for consistent product or market expansions fueling outperformance.
63.60%
3Y revenue/share CAGR above 1.5x 3141.T's 23.78%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-100.00%
Negative 10Y OCF/share CAGR while 3141.T stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-100.00%
Negative 5Y OCF/share CAGR while 3141.T is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-100.00%
Negative 3Y OCF/share CAGR while 3141.T stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
95.12%
Net income/share CAGR at 75-90% of 3141.T's 120.37%. Bill Ackman would press for strategic moves to boost long-term earnings.
95.12%
5Y net income/share CAGR at 75-90% of 3141.T's 120.37%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
58.16%
3Y net income/share CAGR similar to 3141.T's 59.43%. Walter Schloss would attribute it to shared growth factors or demand patterns.
124.82%
10Y equity/share CAGR above 1.5x 3141.T's 49.15%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
124.82%
5Y equity/share CAGR above 1.5x 3141.T's 49.15%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
84.15%
3Y equity/share CAGR above 1.5x 3141.T's 36.79%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-50.00%
Cut dividends over 10 years while 3141.T stands at 4729.69%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-50.00%
Negative 5Y dividend/share CAGR while 3141.T stands at 4729.69%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
30.43%
Our short-term dividend growth is positive while 3141.T cut theirs. John Neff views it as a comparative advantage in shareholder returns.
22462.50%
AR growth of 22462.50% while 3141.T is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
4.04%
We show growth while 3141.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
13.63%
Positive asset growth while 3141.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
5.35%
1.25-1.5x 3141.T's 3.88%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
141.03%
We have some new debt while 3141.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-26.00%
We cut SG&A while 3141.T invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.